Help us understand the experience of alloimmunization during pregnancy
The Alloimmunization during Pregnancy Study aims to better understand the experiences and the financial, social, and economic challenges associated with having testing positive for antibodies (alloimmunization) during pregnancy that needed extra monitoring and care.
We are also interested in hearing perspectives on fetal blood group genotyping, a maternal blood test that can determine the fetus's blood type and guide alloimmunized care.
We are also interested in hearing perspectives on fetal blood group genotyping, a maternal blood test that can determine the fetus's blood type and guide alloimmunized care.
How to participate?
- We are looking for individuals to participate in two 45-minute interviews or one 90-minute virtual interview (participants choice for two shorter or one longer virtual interview) with a member of the research team to share their experience and perspective.
- Participants who complete the interview will receive a $40 gift card.
Next Steps
A member of the study team will contact only those individuals who are eligible to participate. After completing the screening survey, the research team will review responses to determine eligibility. Eligible participants will be contacted using the email address or telephone number they provided to arrange a brief call, during which the study will be explained in more detail and any questions can be answered.
Prior to the interview, eligible participants will receive an electronic consent form to review and sign, as well as a short questionnaire (approximately 10 minutes) to gather background information and learn more about their experiences with testing positive for antibodies during pregnancy.
Sign up for OMama News
Subscribe to stay informed with the latest OMama news and trusted guidance on pregnancy, birth, and early parenting.